News

THE WHITE HOUSE

MAY 20, 2023 -- G7 Hiroshima Leaders’ Communiqué

"... We also reiterate our commitment to addressing global health threats including those exacerbated by climate change, biodiversity loss and pollution through integrated measures and by applying a holistic One Health approach. ..."

SEE: https://www.whitehouse.gov/briefing-room/statements-releases/2023/05/20/g7-hiroshima-leaders-communique/

35. We reaffirm that innovative initiatives including those related to digital health are keys to strengthening GHA and achieving UHC. We will reiterate the urgent need to foster innovation and to strengthen research and development of safe, effective, quality-assured and affordable medical countermeasures (MCMs) as underlined by the 100 Days Mission. We commit to enhancing equitable access to MCM, including by addressing issues relating to manufacturing and delivery. In this regards, we will continue to contribute to ongoing processes, including in the G20, on an end-to-end MCM ecosystem, aligned with the ongoing discussions on the WHO CA+ and which should actively contribute to the diversification of MCM production and address the priority of the most vulnerable partner’s needs and expectations, including in terms of global governance, in cooperation with relevant partners including the WHO, the WB, UN Children’s Fund (UNICEF), the Global Fund, Gavi the Vaccine Alliance, Global Health Innovative Technology (GHIT) Fund, Coalition for Epidemic Preparedness Innovations (CEPI), the Foundation for Innovative New Diagnostics (FIND) and Unitaid and Medicines Patent Pool, regional organizations and the private sector. To this end, we announce the G7 Hiroshima Vision for Equitable Access to MCMs and launch the MCM Delivery Partnership for equitable access (MCDP) to contribute to more equitable access to and delivery of MCMs based on the principles of equity, inclusivity, efficiency, affordability, quality, accountability, agility and speed. We commit to work across providers of development finance, for the purpose of identifying concrete options this summer for providing for the liquidity for global health organizations to procure and deliver MCMs earlier in a crisis. This supports the mapping exercise for surge financing to be conducted by the WHO and World Bank and presented at the G20 Finance and Health Task Force and the UNGA HLM, contributing to ongoing negotiations on the WHO CA+. We also reiterate our commitment to addressing global health threats including those exacerbated by climate change, biodiversity loss and pollution through integrated measures and by applying a holistic One Health approach. Recognizing the rapid escalation of AMR globally, we continue to commit to exploring and implementing push and pull incentives to accelerate R&D of antimicrobials as well as promoting antimicrobial access and stewardship for their prudent and appropriate use toward the UNGA HLM on AMR in 2024. We remain committed to promoting policies and resources to care for people living with dementia and welcome the development of potentially disease modifying therapies for the various types of dementia, including Alzheimer’s disease.